Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yuqing Zhao, Chen Wang, Wei Deng, Lanyang Li, Jiping Liu, Yanghua Shi, Xiang Tao, Jian Zhang, Qi Cao, Chunhui Cai, Xinxin Han |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
by: Changping Deng, et al.
Published: (2025)
by: Changping Deng, et al.
Published: (2025)
Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
by: Shiqi Li, et al.
Published: (2024)
by: Shiqi Li, et al.
Published: (2024)
The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
by: Yu Wu, et al.
Published: (2024)
by: Yu Wu, et al.
Published: (2024)
Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
by: Yunfang Yu, et al.
Published: (2024)
by: Yunfang Yu, et al.
Published: (2024)
Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
by: Lin‐Zhu Zhang, et al.
Published: (2024)
by: Lin‐Zhu Zhang, et al.
Published: (2024)
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
by: Junshu Li, et al.
Published: (2024)
by: Junshu Li, et al.
Published: (2024)
Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
by: Li Zhuang, et al.
Published: (2024)
by: Li Zhuang, et al.
Published: (2024)
Single‐cell atlas of peripheral blood by CyTOF revealed peripheral blood immune cells metabolic alterations and neutrophil changes in intracranial aneurysm rupture
by: Xiaolong Ya, et al.
Published: (2024)
by: Xiaolong Ya, et al.
Published: (2024)
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
by: Siyu Wang, et al.
Published: (2024)
by: Siyu Wang, et al.
Published: (2024)
PA28γ induces dendritic cell maturation and activates T‐cell immune responses in oral lichen planus
by: Yimei Wang, et al.
Published: (2024)
by: Yimei Wang, et al.
Published: (2024)
Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer
by: Jing Li, et al.
Published: (2024)
by: Jing Li, et al.
Published: (2024)
Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
by: Jinwei Li, et al.
Published: (2024)
by: Jinwei Li, et al.
Published: (2024)
Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
by: Jiangchun Wu, et al.
Published: (2024)
by: Jiangchun Wu, et al.
Published: (2024)
Targeting the DNA damage response in cancer
by: Federica Guffanti, et al.
Published: (2024)
by: Federica Guffanti, et al.
Published: (2024)
Patient‐derived xenograft model in cancer: establishment and applications
by: Ao Gu, et al.
Published: (2025)
by: Ao Gu, et al.
Published: (2025)
The interaction of innate immune and adaptive immune system
by: Ruyuan Wang, et al.
Published: (2024)
by: Ruyuan Wang, et al.
Published: (2024)
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
by: Sha Qin, et al.
Published: (2024)
by: Sha Qin, et al.
Published: (2024)
The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
by: Yishan Lu, et al.
Published: (2024)
by: Yishan Lu, et al.
Published: (2024)
Targeting KRAS in Cancer Therapy: Beyond Inhibitors
by: Chunhui Chen, et al.
Published: (2025)
by: Chunhui Chen, et al.
Published: (2025)
5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
by: Jianhua Xia, et al.
Published: (2024)
by: Jianhua Xia, et al.
Published: (2024)
Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
by: Hao Wang, et al.
Published: (2024)
by: Hao Wang, et al.
Published: (2024)
Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
by: TingDan Hu, et al.
Published: (2024)
by: TingDan Hu, et al.
Published: (2024)
Spider minor ampullate silk protein nanoparticles: an effective protein delivery system capable of enhancing systemic immune responses
by: Hairui Yu, et al.
Published: (2024)
by: Hairui Yu, et al.
Published: (2024)
Cardiomyogenic differentiation of an induced pluripotent stem cell line carrying PRKAG2 R302Q mutation
by: Yi Gu, et al.
Published: (2024)
by: Yi Gu, et al.
Published: (2024)
Osteoarthritis synovium as a nidus for monosodium urate crystal deposition inducing severe gout studied by label‐free stimulated Raman scattering combined with synovial organoids
by: Ziyi Chen, et al.
Published: (2025)
by: Ziyi Chen, et al.
Published: (2025)
NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
by: Jiwei Zhang, et al.
Published: (2024)
by: Jiwei Zhang, et al.
Published: (2024)
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
by: Qian Li, et al.
Published: (2024)
by: Qian Li, et al.
Published: (2024)
Time – The fourth dimension of immune cells
by: Guiming Li, et al.
Published: (2024)
by: Guiming Li, et al.
Published: (2024)
The SUMOylated RREB1 interacts with KDM1A to induce 5‐fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer
by: Ya‐Nan Deng, et al.
Published: (2025)
by: Ya‐Nan Deng, et al.
Published: (2025)
Reticulon 3 regulates sphingosine‐1‐phosphate synthesis in endothelial cells to control blood pressure
by: Jie‐Yuan Jin, et al.
Published: (2024)
by: Jie‐Yuan Jin, et al.
Published: (2024)
Single‐cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood‐derived mesenchymal stem cell transplantation
by: Lijun Chen, et al.
Published: (2024)
by: Lijun Chen, et al.
Published: (2024)
Ocular immune‐related diseases: molecular mechanisms and therapy
by: Yakun Wang, et al.
Published: (2024)
by: Yakun Wang, et al.
Published: (2024)
Targets of tumor microenvironment for potential drug development
by: Ling Zhang, et al.
Published: (2024)
by: Ling Zhang, et al.
Published: (2024)
RNA modifications in cancer
by: Han Wu, et al.
Published: (2025)
by: Han Wu, et al.
Published: (2025)
SMARCAL1: a new target for taming tumor immune evasion
by: Ting Xiao, et al.
Published: (2024)
by: Ting Xiao, et al.
Published: (2024)
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
by: Ming Zhou, et al.
Published: (2025)
by: Ming Zhou, et al.
Published: (2025)
The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
by: Yalun Li, et al.
Published: (2024)
by: Yalun Li, et al.
Published: (2024)
Booster vaccination: host preparation against Omicron challenge by innate immunity training
by: Lan Bai, et al.
Published: (2024)
by: Lan Bai, et al.
Published: (2024)
Enhancing the effectiveness of anti‐respiratory virus vaccines by bolstering mucosal immunity and cellular defenses
by: Rubing Xue, et al.
Published: (2024)
by: Rubing Xue, et al.
Published: (2024)
Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
by: Yaqing Liu, et al.
Published: (2025)
by: Yaqing Liu, et al.
Published: (2025)
Similar Items
-
Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
by: Changping Deng, et al.
Published: (2025) -
Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
by: Shiqi Li, et al.
Published: (2024) -
The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
by: Yu Wu, et al.
Published: (2024) -
Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
by: Yunfang Yu, et al.
Published: (2024) -
Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
by: Lin‐Zhu Zhang, et al.
Published: (2024)